Buyon J, et al. LSM 2016 – Reduction in EC4d and anti-C1q antibodies associate with clinical improvement in SLE.View Publication
Putterman C, et al. LSM. 2014. Cell_bound complement activation products in systemic lupus erythematosus.View Publication
Wallace D, et al. LSM. 2016. Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products.View Publication
Dr. Chris Collins
42 Year Old Female African American. Chief complaint: worsening joint pain.
Dr. James Mossell
59 Year Old Caucasian Female. Chief complaint: arthralgias, dry eyes and hair loss.
Dr. Nehad Soloman
18 Year Old Female. Chief Complaint: chronic fatigue and achy joints.
Dr. CJ Alappatt
28 year old Female. Chief Complaint: arthralgia, myalgia and fatigue.
Merrill J, et al. LSM 2018 – Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE.View Publication
Ramsey-Goldman R, et al. LSM 2017 • Cell-bound complement activation products in SLEView Publication
Dr. Priya Reddy
47 Year Old Female. Chief Complaint: overlapping symptoms with ANA positivity.